| Concord Biotech Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
543960
ISIN Demat:
INE338H01029
Book Value(₹): 193.06 NSE Symbol:
CONCORDBIO
Div & Yield(%):
0.60
Market Cap(₹ Cr): 13,062.90 P/E(TTM):
54.22
EPS(TTM):
23.03
Face Value(₹): 1.00 |
| Dec 26 (₹ Cr) | Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 10.46 | 10.46 | 10.46 | 10.46 | 9.51 |
| Reserves | 2,009.29 | 1,802.18 | 1,514.79 | 1,281.52 | 1,097.65 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 2,019.75 | 1,812.64 | 1,525.25 | 1,291.98 | 1,107.16 |
| Secured Loans | 0.00 | 0.38 | 6.23 | 31.24 | 60.59 |
| Unsecured Loans | 0.63 | 2.59 | 3.51 | 0.31 | 1.91 |
| Total Debt | 0.63 | 2.97 | 9.74 | 31.55 | 62.50 |
| Other Liabilities | 3.72 | 2.82 | 1.96 | 2.30 | 1.87 |
| Total Liabilities | 2,024.10 | 1,818.43 | 1,536.95 | 1,325.83 | 1,171.53 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 1,158.91 | 1,095.41 | 825.51 | 791.69 | 719.94 |
| Less: Accumulated Depreciation | 372.50 | 300.73 | 250.20 | 198.71 | 146.97 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 786.41 | 794.68 | 575.31 | 592.98 | 572.97 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 79.32 | 50.66 | 211.48 | 172.70 | 74.16 |
| Investments | 487.69 | 335.20 | 244.37 | 137.72 | 74.39 |
| Current Assets, Loans & Advances | |||||
| Inventories | 325.69 | 239.67 | 207.95 | 212.31 | 195.12 |
| Sundry Debtors | 460.60 | 521.65 | 349.61 | 273.76 | 232.17 |
| Cash and Bank Balance | 9.28 | 1.18 | 47.02 | 43.45 | 88.93 |
| Loans and Advances | 47.58 | 56.20 | 47.94 | 61.25 | 42.97 |
| Total Current Assets | 843.15 | 818.70 | 652.53 | 590.77 | 559.19 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 155.83 | 166.06 | 124.91 | 128.91 | 119.21 |
| Provisions | 11.24 | 15.67 | 9.40 | 36.47 | 1.75 |
| Total CL & Provisions | 167.07 | 181.73 | 134.30 | 165.39 | 120.96 |
| Net Current Assets | 676.08 | 636.97 | 518.23 | 425.39 | 438.23 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 5.55 | 4.13 | 2.45 | 2.18 | 1.95 |
| Deferred Tax Liability | 50.91 | 38.15 | 30.52 | 25.62 | 22.92 |
| Net Deferred Tax | -45.36 | -34.02 | -28.07 | -23.44 | -20.97 |
| Other Assets | 39.96 | 34.94 | 15.62 | 20.48 | 32.74 |
| Total Assets | 2,024.11 | 1,818.43 | 1,536.95 | 1,325.83 | 1,171.52 |
| Contingent Liabilities | 3.76 | 3.91 | 14.31 | 14.31 | 13.32 |
